1,3,4,6,7,11B-HEXAHYDRO-9-HYDROXY-10-METHOXY-3-(2-METHYLPROPYL)-2H-BENZO(A)QUINOLIZIN-2-ONE, REL-(3R,11BS)-
UNII 33BK2H79RR
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,3,4,6,7,11b-hexahydro-9-hydroxy-10-methoxy-3-(2-methylpropyl)-2h-benzo(a)quinolizin-2-one, Rel-(3r,11bs)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 33BK2H79RR.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H25NO3 HFJUFZQVOVHCMY-DZGCQCFKSA-N;HFJUFZQVOVHCMY-HIFRSBDPSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,3,4,6,7,11b-hexahydro-9-hydroxy-10-methoxy-3-(2-methylpropyl)-2h-benzo(a)quinolizin-2-one, Rel-(3r,11bs)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.